Cargando…
Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
COVID-19 results from SARS-CoV-2, which mutates frequently, challenging current treatments. Therefore, it is critical to develop new therapeutic drugs against this disease. This study explores the interaction between SARS-CoV-2 3CL(pro) and RetroMAD1, a well-characterized coronavirus protein and pot...
Autores principales: | Chan, Lee-Chin, Mat Yassim, Aini Syahida, Ahmad Fuaad, Abdullah Al Hadi, Leow, Thean Chor, Sabri, Suriana, Radin Yahaya, Radin Shafierul, Abu Bakar, Awang Muhammad Sagaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656507/ https://www.ncbi.nlm.nih.gov/pubmed/37978223 http://dx.doi.org/10.1038/s41598-023-47511-z |
Ejemplares similares
-
A Review on the Biotechnological Applications of the Operational Group Bacillus amyloliquefaciens
por: Ngalimat, Mohamad Syazwan, et al.
Publicado: (2021) -
Complete Genome Sequence of Photobacterium sp. Strain J15, Isolated from Seawater of Southwestern Johor, Malaysia
por: Roslan, Noordiyanah Nadhirah, et al.
Publicado: (2016) -
Design and Characterisation of Inhibitory Peptides against Bleg1_2478, an Evolutionary Divergent B3 Metallo-β-lactamase
por: Selvaraju, Gayathri, et al.
Publicado: (2020) -
Dehalogenases: From Improved Performance to Potential Microbial Dehalogenation Applications
por: Ang, Thiau-Fu, et al.
Publicado: (2018) -
COVID-19 outbreak in Malaysia: Decoding D614G mutation of SARS-CoV-2 virus isolated from an asymptomatic case in Pahang
por: Mat Yassim, Aini Syahida, et al.
Publicado: (2022)